SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,754,340 | -25.3% | 426,500 | -18.5% | 3.96% | -17.3% |
| Q2 2023 | $15,736,410 | +2.7% | 523,500 | +23.6% | 4.79% | +12.0% |
| Q1 2023 | $15,326,465 | +12.1% | 423,500 | +10.4% | 4.28% | +1.3% |
| Q4 2022 | $13,671,775 | +35.8% | 383,500 | +28.9% | 4.22% | +30.8% |
| Q3 2022 | $10,070,000 | -96.6% | 297,500 | +3357.7% | 3.23% | +4.1% |
| Q2 2022 | $297,500,000 | +1602.1% | 8,604 | -97.1% | 3.10% | -21.3% |
| Q1 2022 | $17,478,000 | +101.5% | 297,500 | 0.0% | 3.94% | +103.9% |
| Q4 2021 | $8,675,000 | +9.3% | 297,500 | 0.0% | 1.93% | +1.0% |
| Q3 2021 | $7,934,000 | +27.3% | 297,500 | +47.0% | 1.91% | +16.3% |
| Q2 2021 | $6,233,000 | +1217.8% | 202,436 | +914.6% | 1.65% | +868.2% |
| Q4 2019 | $473,000 | -13.7% | 19,953 | 0.0% | 0.17% | -32.8% |
| Q3 2019 | $548,000 | -16.8% | 19,953 | 0.0% | 0.25% | +3.7% |
| Q2 2019 | $659,000 | -79.1% | 19,953 | -77.8% | 0.24% | -79.0% |
| Q1 2019 | $3,150,000 | +475.9% | 89,953 | +329.3% | 1.16% | +243.4% |
| Q4 2018 | $547,000 | -32.4% | 20,953 | 0.0% | 0.34% | -11.7% |
| Q3 2018 | $809,000 | -35.4% | 20,953 | 0.0% | 0.38% | -20.2% |
| Q2 2018 | $1,253,000 | +30.7% | 20,953 | 0.0% | 0.48% | +28.6% |
| Q1 2018 | $959,000 | +15.0% | 20,953 | 0.0% | 0.37% | +27.2% |
| Q4 2017 | $834,000 | -0.5% | 20,953 | 0.0% | 0.29% | -9.8% |
| Q3 2017 | $838,000 | -7.1% | 20,953 | 0.0% | 0.33% | -5.0% |
| Q2 2017 | $902,000 | -85.6% | 20,953 | -89.5% | 0.34% | -85.7% |
| Q1 2017 | $6,250,000 | – | 200,000 | – | 2.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |